Theriva Biologics Inc (TOVX)
1.28
+0.02
(+1.59%)
USD |
NYAM |
Nov 21, 16:00
1.23
-0.05
(-3.91%)
After-Hours: 04:58
Theriva Biologics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2010 | 33.71% |
| June 30, 2010 | 93.97% |
| March 31, 2010 | -75.58% |
| December 31, 2009 | -144.0% |
| September 30, 2009 | |
| June 30, 2009 | |
| March 31, 2009 | |
| December 31, 2008 | |
| September 30, 2008 | |
| June 30, 2008 | |
| March 31, 2008 | |
| December 31, 2007 | |
| September 30, 2007 | |
| June 30, 2007 | |
| March 31, 2007 | |
| December 31, 2006 | |
| September 30, 2006 | |
| June 30, 2006 | |
| March 31, 2006 | |
| March 31, 2003 | |
| December 31, 2002 | |
| September 30, 2002 | |
| June 30, 2002 |
| Date | Value |
|---|---|
| March 31, 2002 | |
| December 31, 2001 | |
| September 30, 2001 | |
| June 30, 2001 | |
| March 31, 2001 | |
| December 31, 2000 | 89.69% |
| September 30, 2000 | 28.00% |
| June 30, 2000 | 73.97% |
| March 31, 2000 | 74.41% |
| December 31, 1999 | |
| September 30, 1999 | 0.00% |
| June 30, 1999 | |
| March 31, 1999 | 23.63% |
| December 31, 1998 | |
| September 30, 1998 | |
| June 30, 1998 | |
| March 31, 1998 | |
| December 31, 1997 | |
| September 30, 1997 | |
| June 30, 1997 | |
| March 31, 1997 | |
| December 31, 1996 | |
| September 30, 1996 | 83.33% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Merck & Co Inc | 75.51% |
| Pro-Dex Inc | 34.58% |
| BioCardia Inc | -- |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |